{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:54:31Z","timestamp":1791644071673,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/ijir.2014.37","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T03:55:24Z","timestamp":1416455724000},"page":"75-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Antidepressant treatment of premature ejaculation: discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting"],"prefix":"10.1038","volume":"27","author":[{"given":"P","family":"Jern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Piha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Westberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Santtila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"key":"BFijir201437_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1743-6109.2005.20369.x","volume":"2","author":"F Montorsi","year":"2005","unstructured":"Montorsi F . Prevalence of premature ejaculation: a global and regional perspective. J Sex Med 2005; 2: 96\u2013102.","journal-title":"J Sex Med"},{"key":"BFijir201437_CR2","first-page":"CD008195","volume":"10","author":"T Melnik","year":"2011","unstructured":"Melnik T, Althof S, Atallah AN, Puga ME, Glina S, Riera R . Psychosocial interventions for premature ejaculation. Cochrane Database Syst Rev 2011; 10: CD008195.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFijir201437_CR3","doi-asserted-by":"publisher","first-page":"E943","DOI":"10.1111\/j.1464-410X.2012.11323.x","volume":"110","author":"MG Wyllie","year":"2012","unstructured":"Wyllie MG, Powell JA . The role of local anaesthetics in premature ejaculation. Br J Urol Int 2012; 110: E943\u2013E948.","journal-title":"Br J Urol Int"},{"key":"BFijir201437_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.eururo.2011.01.019","volume":"59","author":"D Sunay","year":"2011","unstructured":"Sunay D, Sunay M, Aydogmus Y, Bagbanci S, Arslan H, Karabulut A, Emir L . Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial. Eur Urol 2011; 59: 765\u2013771.","journal-title":"Eur Urol"},{"key":"BFijir201437_CR5","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1111\/j.1743-6109.2011.02386.x","volume":"8","author":"CG McMahon","year":"2011","unstructured":"McMahon CG, Porst H . Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med 2011; 8: 2707\u20132725.","journal-title":"J Sex Med"},{"key":"BFijir201437_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CE.S13841","volume":"7","author":"EJ McCarty","year":"2012","unstructured":"McCarty EJ, Dinsmore WW . Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation. Core Evid 2012; 7: 1\u201314.","journal-title":"Core Evid"},{"key":"BFijir201437_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","volume":"16","author":"MD Waldinger","year":"2004","unstructured":"Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B . Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004; 16: 369\u2013381.","journal-title":"Int J Impot Res"},{"key":"BFijir201437_CR8","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.3390\/ph3123614","volume":"3","author":"L Osis","year":"2010","unstructured":"Osis L, Bishop JR . Pharmacogenetics of SSRIs and sexual dysfunction. Pharmaceuticals 2010; 3: 3614\u20133628.","journal-title":"Pharmaceuticals"},{"key":"BFijir201437_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fpsyg.2012.00117","volume":"3","author":"PW Andrews","year":"2012","unstructured":"Andrews PW, Anderson Thomson J Jr, Amstadter A, Neale MC . Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Front Psychol 2012; 3: 117.","journal-title":"Front Psychol"},{"key":"BFijir201437_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","volume":"55","author":"J Buvat","year":"2009","unstructured":"Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F . Dapoxetine for the treatment of premature ejaculation: Results from a randomised, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009; 55: 957\u2013968.","journal-title":"Eur Urol"},{"key":"BFijir201437_CR11","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1111\/j.1743-6109.2010.01975.x","volume":"7","author":"SE Althof","year":"2010","unstructured":"Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG et al. International Society for Sexual Medicine\u2019s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010; 7: 2947\u20132969.","journal-title":"J Sex Med"},{"key":"BFijir201437_CR12","first-page":"743","volume":"5","author":"MD Waldinger","year":"2004","unstructured":"Waldinger MD, Olivier B . Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Investig Drugs 2004; 5: 743\u2013747.","journal-title":"Curr Opin Investig Drugs"},{"key":"BFijir201437_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1743-6109.2009.01560.x","volume":"7","author":"CG McMahon","year":"2010","unstructured":"McMahon CG, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010; 7: 256\u2013268.","journal-title":"J Sex Med"},{"key":"BFijir201437_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.urology.2013.05.018","volume":"82","author":"N Mondaini","year":"2013","unstructured":"Mondaini N, Fusco F, Cai T, Benemei S, Mirone V, Bartoletti R . Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a \u201cWaterloo\u201d. Urol 2013; 82: 620\u2013624.","journal-title":"Urol"},{"key":"BFijir201437_CR15","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1111\/j.1743-6109.2009.01404.x","volume":"6","author":"A Salonia","year":"2009","unstructured":"Salonia A, Rocchini L, Sacc\u00e1 A, Pellucchi F, Ferrari M, Carro UD et al. Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation. J Sex Med 2009; 6: 2868\u20132877.","journal-title":"J Sex Med"},{"key":"BFijir201437_CR16","doi-asserted-by":"publisher","first-page":"E77676","DOI":"10.1371\/journal.pone.0077676","volume":"8","author":"P Jern","year":"2013","unstructured":"Jern P, Piha J, Santtila P . Validation of three early ejaculation diagnostic tools: A composite measure is accurate and more adequate for diagnosis by updated diagnostic criteria. PLoS ONE 2013; 8: E77676.","journal-title":"PLoS ONE"},{"key":"BFijir201437_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/jama.288.11.1403","volume":"288","author":"SA Bull","year":"2002","unstructured":"Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002; 288: 1403\u20131409.","journal-title":"JAMA"},{"key":"BFijir201437_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1592\/phco.25.5.660.63590","volume":"25","author":"CD Mullins","year":"2005","unstructured":"Mullins CD, Shaya FT, Meng F, Wang J, Harrison D . Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy 2005; 25: 660\u2013667.","journal-title":"Pharmacotherapy"},{"key":"BFijir201437_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1192\/apt.bp.106.003194","volume":"13","author":"AJ Mitchell","year":"2007","unstructured":"Mitchell AJ, Selmes T . Why don\u2019t patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatr Treat 2007; 13: 336\u2013346.","journal-title":"Adv Psychiatr Treat"},{"key":"BFijir201437_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1756287212453866","volume":"4","author":"CG McMahon","year":"2012","unstructured":"McMahon CG . Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol 2012; 4: 233\u2013251.","journal-title":"Ther Adv Urol"},{"key":"BFijir201437_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","volume":"368","author":"JL Pryor","year":"2006","unstructured":"Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006; 368: 929\u2013937.","journal-title":"Lancet"},{"key":"BFijir201437_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","volume":"326","author":"J Lexchin","year":"2003","unstructured":"Lexchin J, Bero LA, Djulbegovic B, Clark O . Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167.","journal-title":"BMJ"},{"key":"BFijir201437_CR23","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1743-6109.2008.00633.x","volume":"5","author":"MD Waldinger","year":"2008","unstructured":"Waldinger MD, Schweitzer DH . Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case. J Sex Med 2008; 5: 966\u2013997.","journal-title":"J Sex Med"},{"key":"BFijir201437_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1586\/14737175.7.2.107","volume":"7","author":"CU Pae","year":"2007","unstructured":"Pae CU, Patkar AA . Paroxetine: current status in psychiatry. Expert Rev Neurother 2007; 7: 107\u2013120.","journal-title":"Expert Rev Neurother"},{"key":"BFijir201437_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/0022-3514.78.3.524","volume":"78","author":"JM Bailey","year":"2000","unstructured":"Bailey JM, Dunne MP, Martin NG . Genetic and environmental influences on sexual orientation and its correlates in an Australian twin sample. J Pers Soc Psychol 2000; 78: 524\u2013536.","journal-title":"J Pers Soc Psychol"},{"key":"BFijir201437_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1464-410X.2008.08041.x","volume":"103","author":"DL Patrick","year":"2009","unstructured":"Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M . The Premature Ejaculation Profile: Validation of self-reported outcome measures for research and practice. BJU Int 2009; 103: 358\u2013364.","journal-title":"BJU Int"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijir201437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201437","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:11:37Z","timestamp":1648638697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijir201437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFijir201437"],"URL":"https:\/\/doi.org\/10.1038\/ijir.2014.37","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,20]]},"assertion":[{"value":"4 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the past 3 years, the third author (Dr Piha) has received financial compensation from Eli Lilly (lecturer, conducting scientific studies), Janssen-Cilag (conducting scientific studies), PharmaNord (lecturer, consultant) and MEDA (lecturer, consultant). None of the aforementioned have had any role in the present study, including data collection, preparation or analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}